Supplying sodium valproate safely to women and girls

25 July 2019

All members of the pharmacy team should make sure they follow the MHRA’s Pregnancy Prevention Programme (PPP) for sodium valproate every time it is dispensed. 

We spoke to two women whose children were affected by exposure to sodium valproate during their pregnancies, to find out why it’s so important to make sure that women are made aware of the risks when dispensing sodium valproate.

See the previous Regulate article on dispensing sodium valproate safely
 

Related articles

17 December 2020
In this article we have brought together some tips to help you write effective reflective account records, and included a couple of example reflective account records with the feedback they received...
17 December 2020
There’s still time to respond to our consultation Since we launched our consultation on a proposed new approach to managing concerns about pharmacy professionals, we’ve heard from patients and the...
17 December 2020
Take a look at our online guide about the COVID-19 vaccination programme We recognise that pharmacy professionals and pharmacies on our register may have an important role in the COVID-19 vaccination...
17 December 2020
The transition process began on the 31 January 2020 when the United Kingdom left the European Union. During this time, the United Kingdom has continued to be subject to EU rules and remained a member...
22 October 2020
In May, we contacted community pharmacies to ask them to consider providing a Safe Space for people experiencing domestic abuse in their consultation room as part of the UK SAYS NO MORE campaign run...